Abstract Body

Background: The CD4/CD8 ratio correlates with persistent T-cell dysfunction and mortality. We examined the impact of changes (Δ) in the HIV reservoir, systemic inflammation/bacterial translocation and mucosal immunity following ART initiation on CD4/CD8 ratio.

Methods: 33 ART naïve HIV subjects were randomized to efavirenz, maraviroc or maraviroc+raltegravir, each with tenofovir/emtricitabine. Colon and duodenal biopsies were obtained at baseline (BL) and after 9 months of suppressive ART. Duodenal CD4 T-cell density (cells/mm2) was counted by immunofluorescence antibody (IFA) labeling. Tissue was digested into single-cell suspensions for immunophenotyping. Cell-associated HIV RNA and proviral DNA, lymphocyte subsets and activation phenotypes (CD38+/HLA-DR+) were measured in duodenum, and colon, and in peripheral blood (PB) at BL, month 3, 6, and 9. Plasma IL-6, lipoteichoic acid (LTA), sCD14 and zonulin were measured by ELISA. Associations between ΔCD4/CD8 ratio and variations of continuous variables were analyzed using linear mixed models with random intercepts.

Results: The CD4/CD8 ratio significantly improved during ART in all compartments but recovered less in duodenum (all P<0.001). No difference was observed between the regimens (P=0.102) (Figure 1). Higher PB ΔCD4/CD8 ratio was associated with greater decay of HIV-DNA and HIV-RNA. In PB these correlations were significant for both HIV-RNA and HIV-DNA levels (P<0.001), but only PB ΔCD4/CD8 increments predicted colonic RNA-HIV declines (P=0.001). Increases in CD4/CD8 ratio were related to increased zonulin levels (P=0.076).

Higher CD4/CD8 was consistently associated with a lower % of activated CD8 T-cells in PB (Rho -0.74, P<0.001) and colon (Rho -0.48, P=0.002). PB ΔCD4/CD8 increases predicted comparable declines of T-cell activation in PB and colon (P<0.001) and Δnaïve/memory increases in PB and colon (P<0.001), but not any of these phenotypes of CD4 T-cells in duodenum. A higher PB ΔCD4/CD8 ratio was associated with significant improvements of duodenal CD4-T cells/mm2, which still remained profoundly impaired at the end of follow-up (mean CD4 cells/mm2: at baseline, 48, at month 9, 151; in controls: 674; P<0.001).

Conclusions: CD4/CD8 recovery during ART correlates with improvements in markers of viral persistence, T cell activation and T cell maturation in PB and colon. The duodenum may represent a unique compartment for impairment of CD4 maturation and depletion. A quadruple ART regimen did not add detectable benefit to triple ART.

viewer?TAG_ACTION=SECURE_FILE_DOWNLOAD&V
Figure 1. Changes in CD4/CD8 ratio in three compartments during first-line ART.  Individual participant trajectories are represented by grey lines. Dash lines represent levels observed in HIV-uninfected individuals. Red, green and blue lines represent mean changes for each treatment arm predicted by linear mixed-effects models adjusted for baseline CD4 counts.
P values for the interaction between treatment arms and time did not reach statistical significance in any compartment.